Home/Filings/4/0001104659-21-039056
4//SEC Filing

NEIS JOHN 4

Accession 0001104659-21-039056

CIK 0001279704other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 4:06 PM ET

Size

8.4 KB

Accession

0001104659-21-039056

Insider Transaction Report

Form 4
Period: 2021-03-17
NEIS JOHN
Director
Transactions
  • Sale

    Series A Warrants

    2021-03-17$0.28/sh58,640$16,27323,232 total
    Exercise: $30.40From: 2016-04-20Exp: 2021-04-20Common Stock (5,864 underlying)
  • Sale

    Series A Warrants

    2021-03-18$0.25/sh23,232$5,8590 total
    Exercise: $30.40From: 2016-04-20Exp: 2021-04-20Common Stock (2,323 underlying)
Footnotes (2)
  • [F1]The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.27 and $0.2845, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]The price reported is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.24 and $0.27, inclusive. The reporting person undertakes to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Issuer

Cellectar Biosciences, Inc.

CIK 0001279704

Entity typeother

Related Parties

1
  • filerCIK 0001167426

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:06 PM ET
Size
8.4 KB